article thumbnail

The Winning Formula For Life Sciences: Salesforce Life Sciences Cloud And Cloudbyz eClinical Solutions Collaboration

Cloudbyz

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

article thumbnail

Bios launches biotech hub to support life science progress

Drug Discovery World

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Science Trends for 2024 – Xtalks Life Science Podcast Ep. 143

XTalks

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.

article thumbnail

Build Connections with B2B Audiences through the Xtalks Life Science Podcast

XTalks

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

article thumbnail

Awakn Life Sciences receives UK backing for ketamine therapy  

Drug Discovery World

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US. . Awakn Life Sciences has developed a ketamine-assisted therapy programme for treating alcohol use disorder (AUD). Official comments . References .

article thumbnail

Introduction of new drugs without local trial is unscientific & risky as patients here have different anthropometry: Experts

AuroBlog - Aurous Healthcare Clinical Trials blog

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 131
article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.